Critical major airway obstruction due to mediastinal compression is a dreaded, life-threatening illness. Because airway resistance increases exponentially with progressive compression of a major airway, severe respiratory distress may not occur until very late. The management of this condition is challenging and catastrophic outcomes may occur if urgent, appropriate management is not implemented to relieve the mechanical obstruction [1] [2] [3] . Although surgical and bronchoscopic management of major airway obstruction has improved [4] [5] [6] [7] , outcome data on those who are critically ill and require mechanical ventilation in the intensive care unit (ICU) are sparse. We report our experience in the management of patients with critical major airway obstruction and their long-term outcome.
METHODS AND MATERIALS
After obtaining the Ethics Committee and Hospital Institutional Review Board's approval (Approval No. 216/2004), including a waiver of consent from the patients described in the report, a retrospective review was conducted of patients with major airway obstruction by benign or malignant mediastinal masses who were admitted to the cardiothoracic surgical ICU and the medical ICU between January 1996 and February 2011. Hospital records were reviewed and data on the following were collected: patient demographics, clinical features, diagnostic investigations, aetiology, requirements for mechanical ventilation and intervention. Airway evaluation was made based on computed tomography (CT) thorax scans and flexible bronchoscopy. Outcome indices included separation from mechanical ventilation, complications and survival.
SUMMARy
Critical airway obstruction is a dreaded complication of a mediastinal mass. The acute management is difficult and catastrophic outcomes have been reported. A total of 19 patients, aged between 13 and 69 years, who had critical major airway obstruction due to mediastinal mass requiring mechanical ventilation were reviewed. Three patients had benign pathologies (retrosternal goitre, bronchogenic cyst, giant left atrium) and three had lymphoma. The remaining patients had advanced malignancies: metastatic mediastinal lymphadenopathy (n=6), thyroid carcinoma (n=1) and oesophageal carcinoma (n=6). Three patients underwent surgery, three received chemotherapy and 15 had airway stenting under deep intravenous sedation. Apart from one patient who had brain haemorrhage and nosocomial infection after cardiac surgery, all other patients were successfully weaned off ventilation within five days after the interventions to alleviate the major airway obstruction without major complications. All patients were discharged from hospital without supplemental oxygen. Patients who had benign pathologies and lymphoma (n=6, 32%) were still alive after a mean followup period of six years (range 3 to 10) and those with metastatic disease died after a mean survival period of 3.3 months (range 1 to 9). In summary, critical major airway obstruction is caused by a heterogeneous group of mediastinal pathologies, and the definitive treatment and long-term prognosis of these patients are highly dependent on the underlying aetiology. Combining various therapeutic modalities can lead to successful separation of these patients from mechanical ventilation within a short period of time.
RESULTS
During the study period, a total of 19 patients (nine males) with a median age of 54 years (range between 13 and 69 years) were admitted to the ICU with critical major airway obstruction requiring mechanical ventilation. The clinical characteristics of these patients, interventions used and their final outcomes are presented in Table 1 . All patients had a widened mediastinum seen on chest X-ray. In seven patients (Patients 1 to 6 and 16), the diagnosis was made only after admission to the ICU. Three patients had benign pathologies; retrosternal goitre, bronchogenic cyst and giant left atrium 8 diagnosed on CT scan and subsequently confirmed at surgical resection. Patient 3 had echocardiography performed two months previously that showed a giant left atrium (13×12 cm) and severe mitral and tricuspid regurgitation. Three patients had lymphoma suspected on the CT scan and of these, two had emergency transthoracic needle biopsy within a day Ultraflex™ Tracheobronchial Stent System (Boston Scientific, Boston, MA, USA) stents via a flexible bronchoscope under moderate sedation in the ICU. The only other patient who had metallic stents deployed was Patient 7 (Figure 3) . Silicone stents were deployed in the remaining 13 patients. Neodymium-yttrium Aluminum Garnet laser was used in only three of these 13 patients while balloon dilatation was employed for all 15 patients with stenting. In all patients who received anaesthesia for airway stenting, paralytic agents were deliberately omitted.
Outcome
All (except for one) patients had no complications related to the interventions listed in Table 1 and were successfully weaned off the ventilator within five days (mean 1.5 days) after intervention. Immediately after airway stenting, extubation on the operating table was possible for three patients. Patient 3 had a brain haemorrhage and nosocomial infection after cardiac surgery and was successfully weaned off mechanical ventilation 21 days after left atrial plication and tricuspid and mitral valve replacement. Within ten days of transfer out of the ICU, all patients except Patient 3 were discharged alive from the hospital without requiring oxygen therapy. Patient 3 was discharged from the hospital after another 21 days of rehabilitation in the general ward. On follow-up, all six patients with benign pathologies and lymphoma were alive, with a mean follow-up period of six years (range 3 to 10 years). Patient 5 with lymphoma had the silicone stent removed six months later. Four of the 13 patients with metastatic disease had outpatient radiotherapy to the mediastinum and all of these 13 patients died, with a mean survival of 3.3 months (range 1 to 9 months). None had recurrent acute airway disease requiring intervention.
DISCUSSION
There is a paucity of data for patients with mediastinal masses presenting with life-threatening major airway obstruction requiring mechanical ventilation in intensive care. The heterogeneous nature of this group of conditions is highlighted in this case series. As the underlying aetiologies and clinical characteristics were different; a variety of approaches to relieve airway obstruction were applied.
Despite this being a small case series, three distinct subgroups were recognised: surgicallytreatable conditions, chemosensitive tumours and non-chemoresponsive tumours.
Surgically-treatable conditions
In this group of patients (Patients 1 to 3, with mediastinal cyst, retrosternal goitre and atrial enlargement 8 ), definitive surgical correction should be performed urgently to restore airway patency.
Chemosensitive tumours
In these patients (Patients 4 to 6), the mediastinal tumours respond rapidly to chemotherapy. Therefore management should be supportive while awaiting tumour shrinkage and relief of obstruction. Continuous positive airway pressure via facemask in a patient (Patient 6, Figure 1 ) to pneumatically splint the compressed airway 9 was successfully used to avoid intubation. However, as the splinting pressure may be high, bi-level ventilation in spontaneous mode via facemask maybe needed. If non-invasive positive pressure support is unsuccessful, temporary airway stenting is a useful, lifesaving bridging measure until chemotherapy alleviates the mechanical obstruction 10 . The use of ECMO as a last resort has been reported 11 and this was successfully utilised in one of our patients in this series. Because the prognosis of this group of patients is, in general, good with chemotherapy, aggressive intensive care management including the use of ECMO appears warranted 12 .
Non-chemoresponsive tumours
This group (Patients 7 to 19) is made up of mediastinal pathologies that are not suitable for surgery and do not rapidly respond to chemotherapy. These lesions include metastatic lymphadenopathy from various primary malignancies and oesophageal cancers. The management of this group of patients is debatable and the utility of providing aggressive treatment for those with advanced malignancies remains uncertain 13, 14 . Patients with good functional status should be considered for palliative endobronchial stenting (Figures 2 and 3) to prevent death by suffocation and also to facilitate extubation [15] [16] [17] . Although patients in this study had a short mean survival time of 3.3 months, following intervention in the ICU all were discharged from the hospital alive without the need for supplemental oxygen. Adjuvant palliative therapy such as external beam radiotherapy to the mediastinum, chemotherapy or targeted cell therapy in selected patients with reasonable performance status can be considered after discharge from hospitalisation due to the acute airway event. Two of the 13 patients in this series returned to work briefly before succumbing to the malignancy (eight and nine months respectively) after receiving airway stenting and separation from invasive mechanical ventilation. On the other hand, in patients with extensive metastatic disease and poor functional status (European Cooperative Oncology Group performance status 3 or 4), conservative comfort measures may be preferred. Nevertheless, more timely anticipation, identification and palliative treatment of impending airway occlusion in patients with known malignant mediastinal disease can prevent acutely lifethreatening respiratory distress in these patients with advanced malignancy.
Other than specific therapy, general measures adopted to avoid worsening airway obstruction include positioning the patient in the lateral ( Figure  1 ) or upright position and avoiding the use of muscle relaxants or sedatives. Surgery for a huge anterior mediastinal mass performed under general anaesthesia leading to catastrophic airway collapse has been described and this dreaded complication may also occur when a surgical biopsy is performed with intravenous sedation, as illustrated in one of the patients in this study (Patient 4). In the diagnostic work-up, general anaesthesia or intravenous sedation must be avoided whenever possible and alternative methods of obtaining tissue diagnosis should be utilised (e.g. CT-guided biopsy under local anaesthesia only) 18, 19 . Flexible bronchoscopy is often necessary but needs to be carefully considered and planned in accordance to the risk-benefit ratio. When it is performed in a patient who is still breathing spontaneously, emergency airway management including invasive ventilatory support has to be part of the contingency plan. In those who require noninvasive mechanical ventilation, extrinsic positive end-expiratory pressure is useful as a 'pneumatic' splint to maintain intraluminal patency and this can be administered via a nasal or full facemask in relatively stable patients. In spite of these measures, rapid deterioration in respiratory status remains possible and advanced airway management techniques, including the availability of large-bore endotracheal tubes, double-lumen endotracheal tubes, airway stenting and ECMO should be prepared. In terms of major airway stenting, the type of stent used is dependent on the following considerations: 1. The expertise available in the institution. Nonmetallic stents require insertion via a rigid bronchoscope and generally can only be performed when there is expertise to perform rigid bronchoscopy. This procedure is usually performed in the operating theatre under deep intravenous sedation and assisted or jet ventilation. In this case series, only two patients had metallic stents; one patient (Patient 12, Figure 2 ) was deemed to have too high an anaesthetic risk and hence had a metallic stent deployed via a flexible bronchoscope, performed in the ICU, while the other patient (Patient 7, Figure 3 ) had a very critical stenosis at the carinal area where a silicone stent could not be deployed.
The type of airway stenosis. The Food and Drug
Administration suggest caution in the use of metallic stents for benign lesions as it is almost impossible to remove them weeks after deployment in the airway. Balloon dilation has a transient effect of achieving airway patency especially in the setting of critical stenosis from aggressive tumour infiltration or a large extrinsic mass. In this series, balloon dilation was utilised before deployment of stents as the airways were critically stenosed. During airway stenting under anaesthesia, paralytic agents should be avoided as this may lead to complete collapse of the tracheobronchial tree in the proximity of the carina. In essence, the management of patients with critical airway obstruction due to mediastinal mass requires a multidisciplinary team including the intensivist, interventional respiratory physician, radiologist, cardiothoracic surgeon, anaesthetist and cardiopulmonary bypass perfusionist.
CONCLUSION
In this small case series, it is noted that critical major airway obstruction is caused by a heterogeneous group of mediastinal pathologies which can be categorised into three subgroups: a) surgically-treatable conditions, b) chemosensitive tumours, and c) non-chemoresponsive tumours. In those patients who are breathing spontaneously, intravenous sedation or general anaesthesia for diagnostic intervention must be avoided and paralytic agents must not be used during intubation or general anaesthesia. In the intensive care setting, an urgent diagnosis is pivotal because both immediate and definitive treatments are dependent on the underlying aetiological cause of the critical major airway obstruction. Using a multidisciplinary approach to this difficult, life-threatening clinical problem, many patients with critical major airway obstruction can still have a reasonably good outcome, especially if the underlying mediastinal pathology is a benign process or responsive to chemotherapy.
